Pharmacotherapy in Alzheimer's disease: Basis and rationale
- 1 January 1986
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 10 (3-5), 519-531
- https://doi.org/10.1016/0278-5846(86)90022-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Neurochemical Findings in Physiological Aging of the BrainPublished by S. Karger AG ,2015
- Evaluation of Zimeldine in Alzheimer's DiseaseArchives of Neurology, 1985
- Evaluation of an Analogue of Somatostatin (L363,586) in Alzheimer's DiseaseNew England Journal of Medicine, 1985
- Coexistence of Acetylcholinesterase and Somatostatin-Immunoreactivity in Neurons Cultured from Rat CerebrumScience, 1984
- Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)Neurobiology of Aging, 1983
- Measurement of cholinergic drug effects on memory in alzheimer's diseaseNeurobiology of Aging, 1983
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementaNature, 1980